Peter Bains appointed Additional Director of Biocon
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
EC grants conditional marketing authorization based on the EFFISAYIL trial
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
Application includes data from key phase III trials, including the pivotal MOMENTUM trial, which met all primary and key secondary efficacy endpoints
Subscribe To Our Newsletter & Stay Updated